Group 1 - China's foreign exchange reserves increased by $3 billion to $33,464 billion at the end of November, marking a 0.09% rise from the end of October [8] - The People's Bank of China has increased its gold reserves for 13 consecutive months, reaching 7.412 million ounces by the end of November, an increase of 30,000 ounces from the previous month [8] - The National Medical Insurance Directory has added 114 new drugs, including 50 innovative drugs, with five CAR-T therapies included in the commercial insurance list [9] Group 2 - Baidu Group clarified rumors regarding the potential spin-off of its subsidiary Kunlun Chip for independent listing, stating that any such action would require regulatory approval and is not guaranteed [15] - Wuliangye responded to market rumors about a price drop for its flagship product, confirming that the factory price remains unchanged and the reported price changes are due to subsidy policies [16] - First Capital Securities is facing a potential fine of nearly 200 million yuan due to supervisory issues related to a past convertible bond project, highlighting rapid enforcement actions by regulatory bodies [18]
外交部:中方不接受日方所谓交涉,已当场驳回;5款百万元的抗癌药纳入商保;金融产品无法兑付!三家上市公司发声;五粮液回应降价传闻丨每经早参